Cart
sales@molnova.com
[Des-Leu26,Cys(Acm)20,31]-EGF (20-31)
CAS No. ———
[Des-Leu26,Cys(Acm)20,31]-EGF (20-31)( ——— )
Catalog No. M41076 CAS No. ———
[Des-Leu26,Cys(Acm)20,31]-EGF (20-31)
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name[Des-Leu26,Cys(Acm)20,31]-EGF (20-31)
-
NoteResearch use only, not for human use.
-
Brief Description[Des-Leu26,Cys(Acm)20,31]-EGF (20-31)
-
Description[Des-Leu26,Cys(Acm)20,31]-EGF (20-31)
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number———
-
Formula Weight1430.61
-
Molecular FormulaC57H87N15O22S3
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
AD 01
FKBPL (FK506-binding protein like)-based peptide. Binds to and upregulates expression of CD44. Inhibits breast cancer stem cell (BCSC) growth. Decreases pluripotency markers and promotes differentiation of BCSCs. Also inhibits endothelial cell migration as well as tubule and microvessel formation in vitro and in vivo. Blocks tumor growth in xenograft models.
-
(S,R,S)-AHPC-Me
(S,R,S)-AHPC-Me (VHL ligand 2) is the (S,R,S)-AHPC-based VHL ligand used in the recruitment of the von Hippel-Lindau (VHL) protein. (S,R,S)-AHPC-Me can be used to synthesize ARV-771.
-
3-Galloylquercitrin
1. 3''-Galloylquercitrin possesses the activity for PTK inhibition.
